Al Mayadeen English

  • Ar
  • Es
  • x
Al Mayadeen English

Slogan

  • News
    • Politics
    • Economy
    • Sports
    • Arts&Culture
    • Health
    • Miscellaneous
    • Technology
    • Environment
  • Articles
    • Opinion
    • Analysis
    • Blog
    • Features
  • Videos
    • NewsFeed
    • Video Features
    • Explainers
    • TV
    • Digital Series
  • Infographs
  • In Pictures
  • • LIVE
News
  • Politics
  • Economy
  • Sports
  • Arts&Culture
  • Health
  • Miscellaneous
  • Technology
  • Environment
Articles
  • Opinion
  • Analysis
  • Blog
  • Features
Videos
  • NewsFeed
  • Video Features
  • Explainers
  • TV
  • Digital Series
Infographs
In Pictures
  • Africa
  • Asia
  • Asia-Pacific
  • Europe
  • Latin America
  • MENA
  • Palestine
  • US & Canada
BREAKING
Government Media Office in Gaza: So far, 7 bodies have been recovered, while two remain under the rubble, in a scene that epitomizes genocide.
Government Media Office in Gaza: 9 children from one family were killed in an Israeli massacre against the "Al-Najjar" family in Khan Yunis.
Gaza Government Media Office: Over 300 miscarriages have occurred among pregnant women due to the lack of essential nutrients.
Gaza Government Media Office: 26 kidney patients have lost their lives due to the absence of nutritional and medical care.
Gaza Government Media Office: 58 Palestinians have died due to malnutrition, and 242 due to lack of food and medicine.
Ranjbaran to Al Mayadeen: There is a difficult path full of challenges ahead for the indirect talks
Ranjbaran to Al Mayadeen: Defending the Resistance, the Palestinian cause, the Lebanese Resistance, and confronting Zionist crimes throughout the entire region are at the top of the Foreign Minister’s agenda
Ranjbaran to Al Mayadeen:Currently, both Tehran and Washington consider uranium enrichment a red line, but the Americans' red line exists only on paper, whereas our red line is inviolable under any circumstances, and the Americans fully understand this
Ranjbaran to Al Mayadeen: Iranian FM Abbas Araghchi will not back down in the face of US pressure or its media tactics aimed at influencing the other party. They know well that he is a seasoned diplomat who will not lose his way
Ranjbaran to Al Mayadeen: "Israel" has proven that it makes decisions on behalf of the Trump administration and is using all its capabilities to sabotage these talks

CAR T Cell Therapy reaches beyond cancer

  • By Al Mayadeen English
  • Source: Agencies
  • 24 Nov 2022 18:32
  • 1 Shares
4 Min Read

A Penn Medicine CAR T pioneer and a doctoral student in Cell and Molecular Biology discuss the development and progress in treating certain B cell leukemia, lymphoma, and other blood cancers.

  • x
  • CAR T Cell Therapy Reaches Beyond Cancer (Photo: Credit: Keith Chambers / Science Photo Library / Getty Images)
    Researchers have reported highly promising early results for CAR T therapy in a small group of patients with the autoimmune disease lupus. (Photo: Credit: Keith Chambers / Science Photo Library / Getty Images)

Chimeric antigen receptor cells (CAR T), or engineered immune cells, have revealed the ability of personalized immunotherapies to fight blood cancers. Now, researchers have reported highly promising early results for CAR T therapy in a small group of patients with the autoimmune disease lupus. Penn Medicine CAR T pioneer Carl June, MD, and Daniel Baker, a doctoral student in Cell and Molecular Biology in the Perelman School of Medicine at the University of Pennsylvania, discuss this progress in a commentary published today in Cell.

"We've always known that in principle, CAR T therapies could have broad applications, and it's very encouraging to see early evidence that this promise is now being realized," said June, who is the Richard W. Vague Professor in Immunotherapy in the department of Pathology and Laboratory Medicine at Penn Medicine and director of the Center for Cellular Immunotherapies at Penn's Abramson Cancer Center.

Read: Immunotherapy treatment "cures" 2 cancer patients

T cells are among the immune system's most powerful weapons. They can bind to and kill the cells they see as valid targets, including cells infected by viruses. CAR T cells are T cells that have been redirected to effectively kill specifically defined cell types, through genetic engineering.

How are CAR T therapies created?

The cells of each patient are what make CAR T therapies; they are collected from the patient's blood and engineered and multiplied in a lab before they are re-infused into the patient as a "living drug."

The first CAR T therapy, Kymriah, was developed by June and his team at Penn Medicine. It was approved by the Food and Drug Administration in 2017. There are now six FDA-approved CAR T cell therapies in the United States for six different cancers. The therapies have created a revolution in the treatment of certain B cell leukemia, lymphoma, and other blood cancers. Many patients who had little hope have now been put into long-term remission.

Since the beginning of the research, experts believed that T cells could be engineered to fight many conditions other than B cell cancers. These potential new applications are being examined by dozens of research teams around the globe.

The commentary from Baker and June comes in response to the first significant clinical report about the success resulting from these efforts: a paper in Nature Medicine by German researchers on the CAR T therapy used to fight the autoimmune disease lupus (systemic lupus erythematosus).

Lupus, according to researchers, is an obvious choice for CAR T therapy because it, too, is driven by B cells. Thus, experimental CAR T therapies can employ existing anti-B-cell designs. B cells are the immune system's antibody-producing cells, and, in lupus, B cells arise and attack the patient's own organs and tissues.

In the German study, the patients, five young adults, did not benefit from standard lupus treatments. Yet, they all went into remission and were able to stop taking their lupus drugs within three months of a single, relatively small dose of CAR T therapy, which essentially removed their existing B cells.

What was even more noticeable is that all the patients remained in remission during the follow-up period of up to a year, and unlike cancer patients, the lupus patients' B cells came back. They are naturally replenished from blood stem cells in the bone marrow.

June and Baker noted in their commentary that, although the German study's results should be confirmed with bigger studies and longer-term follow-up, they are significantly promising. They suggest that lupus could turn out to be an easier CAR T target than B-cell cancers.

"Disease-driving B cells are much less numerous in lupus," Baker said. "Thus, effective CAR T treatment of this autoimmune disease may require a much lower dose that greatly reduces the problem of immunological side-effects."

  • Cell Therapy
  • Car T
  • Cancer
  • Engineered immune cells

Most Read

YAF say struck 'Israel's' Ben-Gurion Airport with missiles, drones

YAF say struck 'Israel's' Ben Gurion Airport with missiles, drones

  • MENA
  • 18 May 2025
Rachel Accurso criticized for speaking out on Gaza children crisis

Ms. Rachel accused of antisemitism for speaking out for Gaza children

  • Politics
  • 20 May 2025
Martyrs, injuries in violent Israeli bombardment of southern Gaza

Israeli operation fails; IOF launch violent strikes on Gaza

  • Politics
  • 19 May 2025
The spokesperson for the Yemeni Armed Forces, Brigadier General Yahya Saree, giving a statement on Friday, April 11, 2025 (Yemeni Military Media)

Yemeni Armed Forces declare Haifa Port under naval siege

  • Politics
  • 20 May 2025

Coverage

All
War on Gaza

Read Next

All
President Donald Trump, left, departs with U.S. Military Academy Superintendent Lt. Gen. Steven W. Gilland after speaking to United States Military Academy graduating cadets during commencement ceremonies in West Point, N.Y., Saturday, May 24, 2025. (AP)
Politics

Trump: US Army not for imposing democracy or culture abroad

Israeli Prime Minister Benjamin Netanyahu at the Yad LaBanim Memorial in occupied al-Quds, occupied Palestine, on April 29, 2025 (AP)
Politics

Netanyahu Shin Bet pick opposed prisoner swap deal, stirring outrage

Palestinians struggle to receive cooked food distributed at a community kitchen in the Muwasi area of Khan Younis, in the Gaza Strip, Friday, May 23, 2025. (AP)
Politics

UN refuses to cooperate with 'Israel', US firms in Gaza aid scheme

A woman displaying a portrait of martyred Hezbollah leader Hassan Nasrallah, shows her ink-stained thumb after casting her vote at a polling station during municipal elections in the town of Nabatieh, south Lebanon, Saturday, May 24, 2025 (AP)
Politics

Lebanon concludes municipal elections amid Israeli strikes on south

Al Mayadeen English

Al Mayadeen is an Arab Independent Media Satellite Channel.

All Rights Reserved

  • x
  • Privacy Policy
  • About Us
  • Contact Us
  • Authors
Android
iOS